|

EEG Study on Neurophysiological and Psychological Effects of Ericksonian Hypnotherapy in Generalized Anxiety Disorder

RECRUITINGN/ASponsored by Uskudar University
Actively Recruiting
PhaseN/A
SponsorUskudar University
Started2025-02-01
Est. completion2025-07-15
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06811311

Summary

This study examines the neurophysiological and psychological effects of Ericksonian hypnotherapy in individuals diagnosed with Generalized Anxiety Disorder (GAD). Using electroencephalography (EEG), the study aims to assess changes in brain activity and anxiety symptoms before and after treatment. A total of 60 participants will be recruited from both governmental and private psychiatric clinics in Istanbul. Participants will be randomly assigned to either the intervention group (receiving 12 Ericksonian hypnotherapy sessions over 12 weeks) or the control group (receiving no intervention). The primary outcome measures include changes in EEG patterns, specifically alpha, theta, and frontal asymmetry indices, and changes in anxiety severity, measured by the Beck Anxiety Inventory (BAI), Generalized Anxiety Disorder-7 (GAD-7), and State-Trait Anxiety Inventory (STAI). Secondary measures include emotional regulation (DERS) and quality of life (WHOQOL-BREF). This study aims to provide scientific evidence on the effectiveness of Ericksonian hypnotherapy as a complementary treatment for GAD and its impact on brain function and emotional well-being.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Diagnosis of Generalized Anxiety Disorder (GAD) based on DSM-5 criteria
* Aged 18-65 years
* Capable of providing written informed consent
* Fluent in Turkish (for hypnosis and assessments)
* Not currently receiving psychotherapy or pharmacological treatment for anxiety

Exclusion Criteria:

* Presence of comorbid psychiatric disorders (e.g., schizophrenia, bipolar disorder, major depression requiring immediate intervention)
* History of neurological conditions (e.g., epilepsy, traumatic brain injury, stroke)
* Current use of medications affecting EEG activity (e.g., benzodiazepines, SSRIs, antipsychotics)
* Previous experience with hypnotherapy (to avoid expectancy bias)
* Substance abuse or dependence within the last six months
* Pregnancy or breastfeeding
* Severe medical conditions that may interfere with participation

Conditions5

AnxietyAnxiety DisordersGeneralized Anxiety Disorder (GAD)Psychophysiological DisordersStress-Related Disorders

Browse More Trials

Anxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.